This event is no longer available for registration.
The Fine Chemicals Group and Young Chemists’ Panel of the SCI are pleased to announce a series of free webinars that showcase the quality of chemistry presented at their meetings to a wider audience and to provide interesting subject based content during a time when face to face conferences and learning is restricted. This free webinar series will refresh content previously seen at Fine Chemicals Group and Young Chemists’ Panel meetings and include developments, updates and opportunities to find out more. The committees are planning to produce a weekly on-line event starting from early May.
Ainoa Rueda-Zubiaurre, Angelo Sanzone, James Cochrane, Timothy Gorman
Diane Coe, Darren Poole, Joe Mason, Alfie Wills, Tom Grunshaw, Luke Green, Will Maturi-Bailey, Joe Gillions
Andrew Gomm, Chloe Townley, Scott Rice, Alex Hindle and Andrew Harper
Merck Inc. USA - Tuesday 28 July
Neil Strotman is a Director of Chemistry in the Enabling Technologies group within Process Research in Merck Research Laboratories, situated in Rahway, NJ, USA. He received his doctoral training in physical organic/organometallic chemistry at the University of Wisconsin-Madison with Prof. Chuck Casey, before studying nickel mediated cross couplings as a post-doctoral fellow with Prof. Greg Fu at MIT.
Since joining the pharmaceutical industry in 2007, Neil has held various roles at Merck and BMS in catalysis, discovery process chemistry, reaction sciences and engineering, flow chemistry, and process chemistry. In his current role, Neil is the director of the Catalysis Group, Labeled Compound Synthesis Group, and Particle Engineering Lab within Process R&D. He is the author of 30+ publications, and in his free time enjoys traveling with his family and woodworking.
Merck Inc. USA - Tuesday 28 July
Ania Fryszkowska is a Principal Scientist in the group of Enabling Technologies at Merck Research Laboratories (USA). She received her doctoral training in organic chemistry at Warsaw University of Technology (Poland), followed by postdoctoral training with Nigel Scrutton at Manchester Institute of Biotechnology (UK), where she applied enzymatic transformations in stereoselective synthesis of small molecules.
Since her transition to the pharmaceutical industry in 2010, Ania's research focuses on the application of diverse biocatalytic transformations in the discovery and manufacture of therapeutics. In her most recent work, she has been combining the power of directed evolution and enzymatic cascades to construct the structural complexity of non-natural molecules, such as nucleoside analogs. She is the author of 20+scientific publications and 10 patent applications.
Webinars will last for a maximum of 1hr 15 minutes and will take place from 15:00 (UK time) each week on a Tuesday afternoon.
Lectures are tentatively scheduled for the following dates with connection details provided 2 days before the webinar takes place. Registrations will be accepted until 12:00 (UK time) on the day of the webinar.
Tuesday 21 July (15.00 UK time) - Retrosynthesis Special Webinar Session
Evotec, GSK, Leeds
Tuesday 28 July (15.00 UK time) - Synergistic Aerobic Oxidation with a Metalloenzyme and a Transition Metal Activator or Electrocatalyst in the Synthesis of the Key Aldehyde Intermediate
Neil Strotman, Merck Inc. USA
Tuesday 28 July (15.00 UK time) - Development of an enzymatic cascade as the manufacturing route
Ania Fryszkowska , Merck Inc. USA
Further dates will be added, so please check the webpage on a weekly basis.
If you are interested in sponsoring the SCI’s webinar programme, please email email@example.com.
Tel: +44 (0)20 7598 1561
These events are free to attend
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations